| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | 3,282 | 301,000 | 0.23% | ||
| 2 | Axovant Sciences LTD | 26,416 | 303,000 | 0.23% | ||
| 3 | DIREXION PORTFOLIOPLUS SP BIOTCH BL NEW ETF | 11,988 | 329,000 | 0.25% | ||
| 4 | FLUIDIGM CORP DEL COM | 45,000 | 363,000 | 0.28% | ||
| 5 | UNITED THERAPEUTICS CORP DEL | 3,848 | 429,000 | 0.33% | ||
| 6 | KARYOPHARM THERAPEUTICS INC COM | 49,500 | 442,000 | 0.34% | ||
| 7 | PSIVIDA CORP | 180,000 | 482,000 | 0.37% | ||
| 8 | OPHTHOTECH CORP | 12,600 | 533,000 | 0.41% | ||
| 9 | IGNYTA INC COM | 81,000 | 548,000 | 0.42% | ||
| 10 | DICERNA PHARMACEUTICALS INC | 108,000 | 579,000 | 0.45% | ||
| 11 | ZOGENIX INC | 68,130 | 630,000 | 0.49% | ||
| 12 | SERES THERAPEUTICS INC | 24,300 | 645,000 | 0.50% | ||
| 13 | PARATEK PHARMACEUTICALS INC | 45,000 | 683,000 | 0.53% | ||
| 14 | SANOFI SPOND FUNSPONSORED ADR | 90,000 | 753,000 | 0.58% | ||
| 15 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 69,109 | 763,000 | 0.59% | ||
| 16 | ACHILLION PHARMACEUTICALS IN | 99,000 | 764,000 | 0.59% | ||
| 17 | ADAMAS PHARMACEUTICALS INC | 54,000 | 781,000 | 0.60% | ||
| 18 | PROSHARES TR | 45,000 | 853,000 | 0.66% | ||
| 19 | ULTRAGENYX PHARMACEUTICAL INC COM | 13,500 | 855,000 | 0.66% | ||
| 20 | NEW SR INVEST GRP INC COM | 90,000 | 927,000 | 0.72% | ||
| 21 | SPARK THERAPEUTICS INCORPORATED | 31,500 | 930,000 | 0.72% | ||
| 22 | LOXO ONCOLOGY INC COM | 36,000 | 984,000 | 0.76% | ||
| 23 | MEDICINES CO | 40,500 | 1,287,000 | 0.99% | ||
| 24 | HOLOGIC INC | 38,700 | 1,335,000 | 1.03% | ||
| 25 | CLOVIS ONCOLOGY INC | 75,000 | 1,440,000 | 1.11% | ||
| 26 | VERICEL CORP | 298,941 | 1,752,000 | 1.35% | ||
| 27 | PACIRA PHARMACEUTICALS INC | 35,110 | 1,860,000 | 1.44% | ||
| 28 | AGIOS PHARMACEUTICALS INC | 51,000 | 2,071,000 | 1.60% | ||
| 29 | ASTRAZENECA PLC | 79,100 | 2,227,000 | 1.72% | ||
| 30 | EPIZYME INC COM | 189,564 | 2,298,000 | 1.78% | ||
| 31 | PROSHARES TR | 64,462 | 2,635,000 | 2.04% | ||
| 32 | BIOGEN INC | 11,125 | 2,896,000 | 2.24% | ||
| 33 | QIAGEN NV | 135,000 | 3,016,000 | 2.33% | ||
| 34 | REGENERON PHARMACEUTICALS | 8,929 | 3,218,000 | 2.49% | ||
| 35 | PFIZER INC | 110,000 | 3,260,000 | 2.52% | ||
| 36 | VERTEX PHARMACEUTICALS INC | 41,137 | 3,270,000 | 2.53% | ||
| 37 | METTLER-TOLEDO | 9,500 | 3,275,000 | 2.53% | ||
| 38 | ALKERMES PLC | 102,277 | 3,497,000 | 2.70% | ||
| 39 | ILLUMINA INC | 21,729 | 3,522,000 | 2.72% | ||
| 40 | ALEXION PHARMACEUTIC | 25,405 | 3,537,000 | 2.73% | ||
| 41 | INCYTE CORP | 51,677 | 3,745,000 | 2.90% | ||
| 42 | SEATTLE GENETICS INC | 109,922 | 3,857,000 | 2.98% | ||
| 43 | IONIS PHARMACEUTICALS INC COM | 96,808 | 3,921,000 | 3.03% | ||
| 44 | NEKTAR THERAPEUTICS COM | 288,158 | 3,962,000 | 3.06% | ||
| 45 | CELGENE CORP | 39,596 | 3,963,000 | 3.06% | ||
| 46 | BIOMARIN PHARMACEUTICAL INC | 48,260 | 3,980,000 | 3.08% | ||
| 47 | AMGEN INC | 27,184 | 4,076,000 | 3.15% | ||
| 48 | MERCK & CO INC | 90,000 | 4,762,000 | 3.68% | ||
| 49 | ALNYLAM PHARMACEUTICALS INC | 77,593 | 4,871,000 | 3.77% | ||
| 50 | MEDIVATION INC | 106,358 | 4,890,000 | 3.78% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001387131-16-005577, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
